Related Experiment Videos
Hepatitis B serologic studies in narcotic users with chronic liver disease
The American Journal of Gastroenterology
|February 1, 1981
Summary
Nearly all narcotic users with chronic liver disease show signs of Hepatitis B infection. However, alcohol abuse is the primary driver of cirrhosis in this population.
Area of Science:
- Hepatology
- Virology
- Addiction Medicine
Background:
- Chronic liver disease is a significant concern in individuals with a history of narcotic use.
- Hepatitis B virus (HBV) infection is prevalent among substance users.
- Co-existing alcohol abuse complicates the assessment of liver disease etiology.
Purpose of the Study:
- To investigate the prevalence of Hepatitis B markers in narcotic users with chronic liver disease.
- To determine the role of Hepatitis B infection and alcohol abuse in the development of liver pathology.
- To correlate serological findings with liver biopsy results.
Main Methods:
- Radioimmunoassay was used to measure Hepatitis B surface antigen (HBsAg), anti-HBs, and anti-HBc.
- Liver biopsies were performed on 46 current or former narcotic users.
- Alcohol abuse history was assessed, and biopsy findings were categorized.
Main Results:
- Hepatitis B markers were detected in 97.8% of the subjects.
- Cirrhosis was present in 52.2% of patients, chronic active hepatitis in 19.6%, and lipid accumulation in 10.9%.
- Alcohol abuse was reported in 82.6% of the narcotic users, and it was identified as the major factor in cirrhosis development.
Conclusions:
- Active or resolved Hepatitis B infection is nearly universal in narcotic users with chronic liver disease.
- Alcohol abuse plays a more significant role than Hepatitis B in causing cirrhosis in this cohort.
- Comprehensive evaluation including HBV serology and alcohol assessment is crucial for managing liver disease in narcotic users.